Literature DB >> 12410927

Hand-assisted retroperitoneoscopic radical nephrectomy: initial experience.

Akihiro Kawauchi1, Akira Fujito, Osamu Ukimura, Jintetsu Soh, Yoichi Mizutani, Yoichiro Imaide, Tsuneharu Miki.   

Abstract

OBJECTIVES: To report our initial experience of hand-assisted retroperitoneoscopic radical nephrectomy for stage T1 renal tumors.
METHODS: The clinical data on 22 consecutive patients who had undergone hand-assisted retroperitoneoscopic radical nephrectomy and 22 who had undergone open radical nephrectomy were reviewed. The operation was performed with a hand placed retroperitoneally through a pararectal longitudal 7-7.5 cm incision using a LAP DISC.
RESULTS: The total operating time was between 2.3 and 5.8 h (mean: 3.4 h). The estimated blood loss was between 15 and 650 mL (mean: 170 mL). The complication rate was 9% (2/22). No conversions to open procedure occurred. In comparison to open radical nephrectomy, the operating time was similar (3.4 vs 3.9 h) whereas the estimated blood loss was significantly less in this procedure (170 vs 495 mL). During the convalescence period the patients revealed significantly less postoperative pain, shorter intervals to resuming oral intake and more rapid return to normal activities compared to the open radical nephrectomy patients.
CONCLUSION: Hand-assisted retroperitoneoscopic radical nephrectomy is an effective and safe procedure for T1 renal tumors.

Entities:  

Mesh:

Year:  2002        PMID: 12410927     DOI: 10.1046/j.1442-2042.2002.00512.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  2 in total

Review 1.  The advantages of hand-assisted laparoscopy.

Authors:  Ravi Munver; Joseph J Del Pizzo; R Ernest Sosa
Journal:  Curr Urol Rep       Date:  2004-04       Impact factor: 2.862

2.  Comparison of modified hand-assisted retroperitoneoscopic laparoscopic nephrectomy and open nephrectomy in patients with benign inflammatory non-functioning kidney diseases.

Authors:  Weiping Xia; Xiang Chen; Longfei Liu; Zhi Chen; Feng Ru
Journal:  Transl Androl Urol       Date:  2021-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.